Multiple system atrophy (MSA) is a neurodegenerative disorder with limited treatment options. However, recent research has yielded encouraging developments into new therapeutic approaches. Current research centers on modifying the underlying pathophysiology of MSA. One strategy under investigation involves pharmacological interventions to influenc